Inventor · disambiguated record
Ildiko Maria Buck
Also filed as: BUCK ILDIKO · BUCK ILDIKO M · BUCK ILDIKO MARIA
32 granted patents·9 pending applications·348 citations·filing 1990–2024
97Inventor score
Files withASTEX THERAPEUTICS LTD21BLACK JAMES FOUNDATION11OTSUKA PHARMA CO LTD5BUCK ILDIKO M1BUCK ILDIKO MARIA1
Top patents by PatentIndex Score
41 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0295US9458158B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Oct 4, 2016·11 cites·22 claims
- 0393US11225476B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 18, 2022·3 cites·13 claims
- 0492US11866428B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 9, 2024·2 cites·21 claims
- 0592US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 0692US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0792US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0892US9617248B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 0992US9024041B2P38 MAP kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2011·Granted May 5, 2015·27 cites·28 claims
- 1092US5795907AGastin and CCK receptor ligandsBLACK JAMES FOUNDATION·Filed 1994·Granted Aug 18, 1998·75 cites·13 claims
- 1191US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 1291US9783538B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 10, 2017·12 cites·53 claims
- 1390US11643410B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2021·Granted May 9, 2023·1 cites·22 claims
- 1490US9676768B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Jun 13, 2017·8 cites·16 claims
- 1590US9155743B2Bicyclic heterocycle compounds and their uses in therapyBUCK ILDIKO MARIA·Filed 2012·Granted Oct 13, 2015·12 cites·18 claims
- 1689US2025296930A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1787US10618895B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted Apr 14, 2020·4 cites·33 claims
- 1887US9018214B2Bicyclic heterocycle compounds and their uses in therapyWOOLFORD ALISON JO-ANNE·Filed 2012·Granted Apr 28, 2015·13 cites·21 claims
- 1987US5939437ACCK and gastrin receptor ligandsBLACK JAMES FOUNDATION·Filed 1995·Granted Aug 17, 1999·41 cites·6 claims
- 2086US9617283B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 2185US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 2285US2024199607A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2384US12202828B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2022·Granted Jan 21, 2025·0 cites·48 claims
- 2484US5514683ABicyclo 2,2,2!octane derivativesBLACK JAMES FOUNDATION·Filed 1994·Granted May 7, 1996·29 cites·19 claims
- 2583US11466016B2Pharmaceutical compoundsOTSUKA PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·2 cites·27 claims
- 2682US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2782US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 2873US6878734B2Gastrin and cholecystokinin receptor ligands(II)BLACK JAMES FOUNDATION·Filed 2001·Granted Apr 12, 2005·5 cites·14 claims
- 2972US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 3070US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 3167US5919829AGastrin and cck receptor ligandsBLACK JAMES FOUNDATION·Filed 1998·Granted Jul 6, 1999·28 cites·11 claims
- 3267US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3367US2019375748A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3461US2017334907A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 3552US6479531B1Gastrin and cholecystokinin receptor ligandsBLACK JAMES FOUNDATION·Filed 1999·Granted Nov 12, 2002·14 cites·23 claims
- 3646US6878736B1Histamine H3 receptor ligandsBLACK JAMES FOUNDATION·Filed 1999·Granted Apr 12, 2005·7 cites·11 claims
- 3746US2007185093A1Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligandsBUCK ILDIKO M·Filed 2004·Application pending·0 cites
- 3840US2006003993A1Benzotriazepnes as gastrin and cholecystokinin receptor ligandsBLACK JAMES FOUNDATION·Filed 2002·Application pending·0 cites
- 3939US7034048B2Gastrin and cholecystokinin receptor ligands (III)BLACK JAMES FOUNDATION·Filed 2001·Granted Apr 25, 2006·0 cites·22 claims
- 4036US5486597ATetrapeptide derivatives and analoguesBLACK JAMES FOUNDATION·Filed 1991·Granted Jan 23, 1996·3 cites·24 claims
- 4131US6407132B1Substituted imidazole derivatives and their use as histamine H3 receptor ligandsBLACK JAMES FOUNDATION·Filed 1990·Granted Jun 18, 2002·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →